Regenerative Medical Technology Group Statistics
Want to see RMTG full AI Analyst Report?
Regenerative Medical Technology Group (RMTG) Stock Statistics & Valuation Metrics
Total Valuation
Regenerative Medical Technology Group has a market cap or net worth of $478.12K. The enterprise value is $21.03M.
- Market Cap
- $478.12K
- Enterprise Value
- $21.03M
Share Statistics
Regenerative Medical Technology Group has 13,738,968 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 13,738,968
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Regenerative Medical Technology Group’s return on equity (ROE) is 0.22 and return on invested capital (ROIC) is 5.71%.
- Return on Equity (ROE)
- 0.22
- Return on Assets (ROA)
- -1.74
- Return on Invested Capital (ROIC)
- 5.71%
- Return on Capital Employed (ROCE)
- 0.03
- Revenue Per Employee
- 5.10M
- Profits Per Employee
- -7.81M
- Employee Count
- 1
- Asset Turnover
- 1.14
- Inventory Turnover
- 14.37
Valuation Ratios
The current PE Ratio of Regenerative Medical Technology Group is -0.05. Regenerative Medical Technology Group’s PEG ratio is 0.00.
- PE Ratio
- -0.05
- PS Ratio
- 0.05
- PB Ratio
- -0.01
- Price to FCF
- -0.80
- Price to Operating Cash Flow
- 1.66
- PEG Ratio
- 0.00
Income Statement
In the last 12 months, Regenerative Medical Technology Group had revenue of 5.10M and earned -7.81M in profits. Earnings per share was -0.62.
- Revenue
- 5.10M
- Gross Profit
- 2.81M
- Operating Income
- -867.16K
- Pretax Income
- -7.81M
- Net Income
- -7.81M
- EBITDA
- -83.56K
- Earnings Per Share (EPS)
- -0.62
Cash Flow
In the last 12 months, operating cash flow was 268.56K and capital expenditures -850,894, giving a free cash flow of -582.33K billion.
- Operating Cash Flow
- 268.56K
- Free Cash Flow
- -582.33K
- Free Cash Flow per Share
- -0.04
Dividends & Yields
Regenerative Medical Technology Group pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -125.55%
- Earnings Yield
- -2134.23%
Stock Price Statistics
- Beta
- -1.58
- 52-Week Price Change
- -42.37%
- 50-Day Moving Average
- 0.05
- 200-Day Moving Average
- 0.05
- Relative Strength Index (RSI)
- 25.28
- Average Volume (3m)
- 58.56K
Important Dates
Regenerative Medical Technology Group upcoming earnings date is ―, Before Open (Confirmed).
- Last Earnings Date
- Aug 20, 2026
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Financial Position
Regenerative Medical Technology Group as a current ratio of 0.03, with Debt / Equity ratio of -56.32%
- Current Ratio
- 0.03
- Quick Ratio
- 0.03
- Debt to Market Cap
- 31.61
- Net Debt to EBITDA
- -222.73
- Interest Coverage Ratio
- -0.12
Taxes
In the past 12 months, Regenerative Medical Technology Group has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Regenerative Medical Technology Group EV to EBITDA ratio is 10.47, with an EV/FCF ratio of -35.86.
- EV to Sales
- 2.22
- EV to EBITDA
- 10.47
- EV to Free Cash Flow
- -35.86
- EV to Operating Cash Flow
- 77.75
Balance Sheet
Regenerative Medical Technology Group has $1.32M in cash and marketable securities with $21.74M in debt, giving a net cash position of -$20.42M billion.
- Cash & Marketable Securities
- $1.32M
- Total Debt
- $21.74M
- Net Cash
- -$20.42M
- Net Cash Per Share
- -$1.49
- Tangible Book Value Per Share
- -$3.10
Margins
Gross margin is 58.55%, with operating margin of 0.46%, and net profit margin of -101.21%.
- Gross Margin
- 58.55%
- Operating Margin
- 0.46%
- Pretax Margin
- -101.21%
- Net Profit Margin
- -101.21%
- EBITDA Margin
- 21.19%
- EBIT Margin
- 17.34%
Analyst Forecast
The average price target for Regenerative Medical Technology Group is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 94.32%
- EPS Growth Forecast
- -158.38%
Scores
- Smart Score
- ―
- AI Score
- 43

